Mesh Bio

A scientist checking on results of their DNA analysis on a digital tablet

Mesh Bio refining digital twin tech for chronic disease management and more briefs

By Adam Ang 12:14 am October 20, 2023

Mesh Bio secures funding for refining digital twin engine Singaporean startup Mesh Bio has received undisclosed funding from East Ventures to assist with its regional expansion. The company is currently working on a digital twin solution for managing rising cases of chronic diseases, particularly in Southeast Asia, where 62% of all deaths in the region are due to non-communicable conditions. Mesh...

Mesh Bio, MultiOmic Health to generate AI-driven insights on Asian metabolic diseases

By Adam Ang 03:05 am June 30, 2022

Singaporean health tech startup Mesh Bio and UK-based drug discovery firm MultiOmic Health have started collaborating to build a huge multi-omics dataset that will provide insights into metabolic syndrome-related conditions among Asians. WHAT IT'S ABOUT According to a press statement, Mesh Bio will tap on its network of healthcare providers to recruit participants for their study, specifically...